EXPRESSION OF EPSTEIN-BARR VIRUS-ENCODED RNAS AS A MARKER FOR METASTATIC UNDIFFERENTIATED NASOPHARYNGEAL CARCINOMA

Citation
Ty. Chao et al., EXPRESSION OF EPSTEIN-BARR VIRUS-ENCODED RNAS AS A MARKER FOR METASTATIC UNDIFFERENTIATED NASOPHARYNGEAL CARCINOMA, Cancer, 78(1), 1996, pp. 24-29
Citations number
31
Categorie Soggetti
Oncology
Journal title
CancerACNP
ISSN journal
0008543X
Volume
78
Issue
1
Year of publication
1996
Pages
24 - 29
Database
ISI
SICI code
0008-543X(1996)78:1<24:EOEVRA>2.0.ZU;2-4
Abstract
BACKGROUND. Epstein-Barr virus (EBV) is associated with undifferentiat ed nasopharyngeal carcinoma (NPC). EBV-encoded nonpolyadenylated RNAs (EBERs) are often used as a marker to detect EBV-infected NPC cells. T his study was conducted to document the expression and determine the s ignificance of EBERs in NPC cells at various metastatic sites. METHODS . An in situ hybridization (ISH) technique was used to identify the pr esence of EBERs in paraffin embedded tissues of primary and metastatic sites obtained from 21 patients with NPC. Nineteen of these patients had undifferentiated lesions, and 2 had squamous cell carcinoma. One h undred and fifty specimens of normal tissues and tissues from patients with a variety of benign and malignant diseases other than NPC served as controls. In the NPC specimens, the expression of latent membrane protein (LMP) and a lytic protein, BZLF-1, were also examined by immun ohistochemistry. RESULTS. Tissues from all patients with undiffferenti ated NPC and one patient with squamous cell carcinoma contained EBERs in the malignant cells; the other case of squamous cell carcinoma was negative. In metastatic NPCs, LMP was expressed in 18% (4 of 22) of ti ssues whereas BZLF-1 was not expressed in any tissues. EBERs were not detected in the 43 patients with normal tissues and benign lesions. In malignant diseases other than NPC, EBERs were detected in only 2 of 1 2 cases of non-Hodgkin's lymphoma, 1 of 2 cases of Hodgkin's lymphoma, and 1 of 6 cases of gastric cancer. CONCLUSIONS. By virtue of the dir ect correlation between latent EBV infection and NPC, the authors conc lude that EBERs can be used as a sensitive marker to identify NPC cell s at various metastatic sites by techniques of in situ hybridization, and that demonstration of EBERs in lesions of undifferentiated histolo gy may be useful as a diagnostic adjunct for NPC presenting as metasta tic cancer of unknown origin.